Pill Identifier App

AN 415 (Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base))

Pill imprint AN 415 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.

See also related documents.

Imprint Search

Images for AN 415

Buprenorphine hydrochloride and naloxone hydrochloride 8 mg (base) / 2 mg (base) AN 415
Buprenorphine hydrochloride and naloxone hydrochloride
Imprint:
AN 415
Strength:
8 mg (base) / 2 mg (base)
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Amneal Pharmaceuticals
National Drug Code (NDC):
65162-0415
Inactive Ingredients:
acesulfame potassium
citric acid anhydrous
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
mannitol
povidone
sodium citrate
corn starch

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)